Health Canada — Medical Devices · Canada · 2012-11-26 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: The currently available knowledgebase, Vitek MS Version 2.0, is known to have lower performance for the nine (9) mycobacteria species listed in the knowledgebase user manual supplement. Additionally, an internal study determined that in rare circumstances the current mycobacteria protocol might not completely inactivate multi drug resistant (MDR) M. tuberculosis when using 30/70 TFA/ETOH (trifluoroacetic/ethanol).
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.